Tumour markers of prognosis in colorectal cancer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

46 citing papers in PubMed.

1. Optimized workup of lymph nodes in regard to UICC classification of colorectal carcinoma.Histopathology · 2026
   Article
2. Open, Laparoscopic, and Robotic Approaches to Treat Colorectal Cancer: A Comprehensive Review of Literature.Cureus · 2023
   Review
3. Recurrence-Free Survival Outcomes Based on Novel Classification Combining Lymphovascular Invasion, Perineural Invasion, and T4 Status in Stage II-III Colon Cancer.Cancer management and research · 2022
   Article
4. A Novel Prognostic Model Incorporating Carcinoembryonic Antigen in 3-Week or Longer Postoperative Period for Stage III Colon Cancer: A Multicenter Retrospective Study.Frontiers in oncology · 2020
   Article
5. New frontiers in the treatment of colorectal cancer: Autophagy and the unfolded protein response as promising targets.Autophagy · 2017
   Review
6. High expression of matrix metalloproteinases 16 is associated with the aggressive malignant behavior and poor survival outcome in colorectal carcinoma.Scientific reports · 2017
   Article
7. Interleukin-22 promotes aerobic glycolysis associated with tumor progression via targeting hexokinase-2 in human colon cancer cells.Oncotarget · 2017
   Article
8. MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance.Virchows Archiv : an international journal of pathology · 2016
   Article
9. Secretion of N- and O-linked Glycoproteins from 4T1 Murine Mammary Carcinoma Cells.International journal of medical sciences · 2016
   Article
10. Identification of Phosphorylated Cyclin-Dependent Kinase 1 Associated with Colorectal Cancer Survival Using Label-Free Quantitative Analyses.PloS one · 2016
    Article
11. Expression of P33(ING1b) Protein in Colorectal Cancer.Middle East journal of digestive diseases · 2016
    Article
12. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.Oncotarget · 2015
    Article
13. Prognostic significance of matrix metalloproteinase 7 immunohistochemical expression in colorectal cancer: a meta-analysis.International journal of clinical and experimental medicine · 2015
    Article
14. Tissue-based biomarkers predicting outcomes in metastatic colorectal cancer: a review.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2014
    Review
15. Prognostic stratification of colorectal cancer patients: current perspectives.Cancer management and research · 2014
    Review
16. Evaluation and prognostic significance of human tissue kallikrein-related peptidase 10 (KLK10) in colorectal cancer.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2012
    Article
17. Dilated SMV in colon cancer--is there any significance.Journal of gastrointestinal cancer · 2012
    Article
18. Prognostic value of colorectal cancer biomarkers.Cancers · 2011
    Article
19. The proteomics of colorectal cancer: identification of a protein signature associated with prognosis.PloS one · 2011
    Article
20. Quantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma.British journal of cancer · 2010
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as